Can exercise help pancreatic cancer patients get stronger before treatment?

NCT ID NCT05692323

First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 28 times

Summary

This study is testing whether a 6-week supervised exercise program is practical and safe for people with pancreatic cancer. Sixteen participants will do aerobic and resistance training three times a week, plus home exercise tracked by a FitBit. The main goal is to see if patients can stick with the program, not to measure health outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Cedars-Sinai Medical Center

    Los Angeles, California, 90048, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

supervised exercise program (aerobic and resistance training)

What this could lead to

If successful, this could show that a structured exercise program is practical and safe for pancreatic cancer patients, potentially improving their fitness before treatment.

What could go wrong

This is a very small early-stage trial with only 16 participants, focused on feasibility rather than health outcomes. The program may not be suitable for all patients or may not lead to clear benefits.

Conditions

The condition(s) this trial relates to.

malignant pancreatic neoplasm Motor Activity pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.